- Home
- TPR vs BNTX Comparison
TPR vs BNTX Comparison
Compare TPR & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TPR | BNTX |
|---|---|---|
| Founded | 1941 | 2008 |
| Country | United States | Germany |
| Employees | 20600 | 7807 |
| Industry | Apparel | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.7B | 24.7B |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | TPR | BNTX |
|---|---|---|
| Price | $117.89 | $97.10 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 13 |
| Target Price | ★ $145.44 | $133.46 |
| AVG Volume (30 Days) | ★ 3.5M | 1.5M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 786.59 | N/A |
| EPS | ★ 7.27 | N/A |
| Revenue | ★ $5,880,000,000.00 | N/A |
| Revenue This Year | $12.39 | N/A |
| Revenue Next Year | $5.36 | $3.37 |
| P/E Ratio | $15.64 | ★ N/A |
| Revenue Growth | ★ 31.01 | N/A |
| 52 Week Low | $93.00 | $79.81 |
| 52 Week High | $164.80 | $124.00 |
Technical Indicators
Market Signals| Indicator | TPR | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 29.10 | 42.40 |
| Support Level | N/A | $88.36 |
| Resistance Level | $147.88 | $98.81 |
| Average True Range (ATR) | 3.45 | 3.37 |
| MACD | -0.91 | -1.62 |
| Stochastic Oscillator | 16.75 | 0.55 |
Price Performance
Historical ComparisonAbout TPR Tapestry Inc.
Based in New York City, Tapestry is the parent company of accessories and fashion brand Coach, which accounted for 86% of its revenue and all its operating profit in fiscal 2026. Coach was founded as a leathergoods company in 1941, and handbags represented 58% of its fiscal 2026 revenue. Coach products are sold through nearly 1,000 company-owned stores, company-operated digital channels, and wholesale partners in North America, Asia, and Europe. Tapestry also owns Kate Spade (13% of fiscal 2026 revenue), which operates more than 300 worldwide stores and generated 55% of its revenue from handbags in fiscal 2025. Founded in 1993, Kate Spade is known for its colorful patterns and graphics.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.